Immunogenic death of colon cancer cells treated with oxaliplatin

生物 免疫系统 癌症研究 免疫学 分子生物学 细胞凋亡 免疫原性细胞死亡 癌细胞 免疫疗法 癌症 遗传学 生物化学
作者
Antoine Tesnière,Frédéric Schlemmer,Valérie Boige,Oliver Kepp,Isabelle Martins,François Ghiringhelli,Laetitia Aymeric,Mickaël Michaud,Lionel Apétoh,Ludovic Barault,Jean Mendiboure,Jean‐Pierre Pignon,Valérie Jooste,Peter Van Endert,Michel Pierre Ducreux,Laurence Zitvogel,F Piard,Guido Kroemer
出处
期刊:Oncogene [Springer Nature]
卷期号:29 (4): 482-491 被引量:1224
标识
DOI:10.1038/onc.2009.356
摘要

Both the pre-apoptotic exposure of calreticulin (CRT) and the post-apoptotic release of high-mobility group box 1 protein (HMGB1) are required for immunogenic cell death elicited by anthracyclins. Here, we show that both oxaliplatin (OXP) and cisplatin (CDDP) were equally efficient in triggering HMGB1 release. However, OXP, but not CDDP, stimulates pre-apoptotic CRT exposure in a series of murine and human colon cancer cell lines. Subcutaneous injection of OXP-treated colorectal cancer (CRC), CT26, cells induced an anticancer immune response that was reduced by short interfering RNA-mediated depletion of CRT or HMGB1. In contrast, CDDP-treated CT26 cells failed to induce anticancer immunity, unless recombinant CRT protein was absorbed into the cells. CT26 tumors implanted in immunocompetent mice responded to OXP treatment in vivo, and this therapeutic response was lost when CRT exposure by CT26 cells was inhibited or when CT26 cells were implanted in immunodeficient mice. The knockout of toll-like receptor 4 (TLR4), the receptor for HMGB1, also resulted in a deficient immune response against OXP-treated CT26 cells. In patients with advanced (stage IV, Duke D) CRC, who received an OXP-based chemotherapeutic regimen, the loss-of-function allele of TLR4 (Asp299Gly in linkage disequilibrium with Thr399Ile, reducing its affinity for HMGB1) was as prevalent as in the general population. However, patients carrying the TLR4 loss-of-function allele exhibited reduced progression-free and overall survival, as compared with patients carrying the normal TLR4 allele. In conclusion, OXP induces immunogenic death of CRC cells, and this effect determines its therapeutic efficacy in CRC patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
shocwk发布了新的文献求助10
刚刚
lyl发布了新的文献求助30
1秒前
Owen的应助被天天采纳,获得10
1秒前
小蘑菇的应助被天天采纳,获得10
1秒前
传奇3的应助被天天采纳,获得10
1秒前
Jasper的应助被积极的含灵采纳,获得10
1秒前
CodeCraft的应助被天天采纳,获得10
1秒前
可爱的函函的应助被天天采纳,获得10
1秒前
fangmeiyuan完成签到,获得积分10
2秒前
斯文败类的应助被天天采纳,获得10
2秒前
李爱国的应助被天天采纳,获得10
2秒前
天天快乐的应助被天天采纳,获得10
2秒前
完美世界的应助被天天采纳,获得10
2秒前
JamesPei的应助被天天采纳,获得10
2秒前
zhi完成签到,获得积分10
4秒前
carrot完成签到,获得积分10
5秒前
刘刘发布了新的文献求助10
6秒前
nunl发布了新的文献求助10
6秒前
岳雨萌完成签到,获得积分20
6秒前
墨雪归青完成签到,获得积分10
7秒前
金常常完成签到,获得积分10
8秒前
8秒前
momo完成签到 ,获得积分10
11秒前
11秒前
烟花的应助被zzz采纳,获得10
12秒前
NexusExplorer的应助被费洛蒙漩涡采纳,获得10
12秒前
沉静俊驰完成签到,获得积分10
13秒前
14秒前
奋斗者完成签到,获得积分10
14秒前
15秒前
打打的应助被科研通管家采纳,获得10
16秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
16秒前
共享精神的应助被科研通管家采纳,获得10
16秒前
我是老大的应助被ff采纳,获得10
16秒前
木9发布了新的文献求助10
16秒前
小马甲的应助被科研通管家采纳,获得10
16秒前
李健的应助被科研通管家采纳,获得10
16秒前
超级无敌的应助被科研通管家采纳,获得10
16秒前
慕青的应助被科研通管家采纳,获得10
17秒前
zxqzxq完成签到,获得积分10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191314
求助须知:如何正确求助?哪些是违规求助? 9578210
关于积分的说明 21857267
捐赠科研通 7790624
什么是DOI,文献DOI怎么找? 3436606
关于科研通互助平台的介绍 2560359
邀请新用户注册赠送积分活动 2483305